Literature DB >> 21570474

Stepwise increase of resveratrol biosynthesis in yeast Saccharomyces cerevisiae by metabolic engineering.

Yechun Wang1, Coralie Halls, Juan Zhang, Michiyo Matsuno, Yansheng Zhang, Oliver Yu.   

Abstract

Resveratrol is a unique, natural polyphenolic compound with diverse health benefits. In the present study, we attempted to improve resveratrol biosynthesis in yeast by different methods of metabolic engineering. We first mutated and then re-synthesized tyrosine ammonia lyase (TAL) by replacing the bacteria codons with yeast-preferred codons, which increased translation and improved p-coumaric acid and resveratrol biosynthesis drastically. We then demonstrated that low-affinity, high-capacity bacterial araE transporter could enhance resveratrol accumulation, without transporting resveratrol directly. Yeast cells carrying the araE gene produced up to 2.44-fold higher resveratrol than control cells. For commercial applications, resveratrol biosynthesis was detected in sucrose medium and fresh grape juice using our engineered yeast cells. In collaboration with the Chaumette Winery of Missouri, we were able to produce resveratrol-containing white wines, with levels comparable to the resveratrol levels found in most red wines.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21570474     DOI: 10.1016/j.ymben.2011.04.005

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  24 in total

Review 1.  Computational tools for metabolic engineering.

Authors:  Wilbert B Copeland; Bryan A Bartley; Deepak Chandran; Michal Galdzicki; Kyung H Kim; Sean C Sleight; Costas D Maranas; Herbert M Sauro
Journal:  Metab Eng       Date:  2012-05       Impact factor: 9.783

Review 2.  Metabolic engineering of strains: from industrial-scale to lab-scale chemical production.

Authors:  Jie Sun; Hal S Alper
Journal:  J Ind Microbiol Biotechnol       Date:  2014-11-21       Impact factor: 3.346

Review 3.  Heterologous production of curcuminoids.

Authors:  J L Rodrigues; K L J Prather; L D Kluskens; L R Rodrigues
Journal:  Microbiol Mol Biol Rev       Date:  2015-03       Impact factor: 11.056

Review 4.  Yeast factories for the production of aromatic compounds: from building blocks to plant secondary metabolites.

Authors:  Miguel Suástegui; Zengyi Shao
Journal:  J Ind Microbiol Biotechnol       Date:  2016-08-31       Impact factor: 3.346

Review 5.  Engineered biosynthesis of natural products in heterologous hosts.

Authors:  Yunzi Luo; Bing-Zhi Li; Duo Liu; Lu Zhang; Yan Chen; Bin Jia; Bo-Xuan Zeng; Huimin Zhao; Ying-Jin Yuan
Journal:  Chem Soc Rev       Date:  2015-05-11       Impact factor: 54.564

6.  Putting bugs to the blush: metabolic engineering for phenylpropanoid-derived products in microorganisms.

Authors:  Philana V van Summeren-Wesenhagen; Jan Marienhagen
Journal:  Bioengineered       Date:  2013-11-18       Impact factor: 3.269

7.  Highly Active and Specific Tyrosine Ammonia-Lyases from Diverse Origins Enable Enhanced Production of Aromatic Compounds in Bacteria and Saccharomyces cerevisiae.

Authors:  Christian Bille Jendresen; Steen Gustav Stahlhut; Mingji Li; Paula Gaspar; Solvej Siedler; Jochen Förster; Jérôme Maury; Irina Borodina; Alex Toftgaard Nielsen
Journal:  Appl Environ Microbiol       Date:  2015-04-24       Impact factor: 4.792

Review 8.  Improving industrial yeast strains: exploiting natural and artificial diversity.

Authors:  Jan Steensels; Tim Snoek; Esther Meersman; Martina Picca Nicolino; Karin Voordeckers; Kevin J Verstrepen
Journal:  FEMS Microbiol Rev       Date:  2014-05-08       Impact factor: 16.408

Review 9.  Biotechnological production of specialty aromatic and aromatic-derivative compounds.

Authors:  A Braga; N Faria
Journal:  World J Microbiol Biotechnol       Date:  2022-03-26       Impact factor: 3.312

10.  Engineering microbial cells for the biosynthesis of natural compounds of pharmaceutical significance.

Authors:  Philippe Jeandet; Yann Vasserot; Thomas Chastang; Eric Courot
Journal:  Biomed Res Int       Date:  2013-04-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.